Long-term effects of pergolide in the treatment of restless legs syndrome

被引：78
|
作者：
Stiasny, K
Wetter, TC
Winkelmann, J
Brandenburg, U
Penzel, T
Rubin, M
Hundemer, HP
Oertel, WH
Trenkwalder, C
机构：
[1] Univ Marburg, Dept Neurol, Ctr Nervous Dis, D-35033 Marburg, Germany
[2] Univ Marburg, Dept Internal Med, Marburg, Germany
[3] Lilly Deutschland GMBH, Bad Homburg, Germany
来源：
NEUROLOGY | 2001年 / 56卷 / 10期
关键词：
D O I：
10.1212/WNL.56.10.1399
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
An open follow-up of a controlled study in patients with restless legs syndrome (RLS) shows that the beneficial effect of pergolide on RLS symptoms persists throughout at least 1 year. Twenty-two patients of 28 (78.6%) continued to take pergolide. Polysomnographic measurements showed a persistent improvement of PLM index, PLMS arousal index, total sleep time, and sleep efficiency (p = 0.0001). Side effects, in particular nausea, were common but were well controlled by domperidone in most patients.
引用
收藏
页码：1399 / 1402
页数：4
相关论文
共 50 条
  • [31] Pleuropulmonary disease due to pergolide use for restless legs syndrome
    Danoff, SK
    Grasso, ME
    Terry, PB
    Flynn, JA
    CHEST, 2001, 120 (01) : 313 - 316
  • [32] A randomized controlled study of pergolide in patients with restless legs syndrome
    Wetter, TC
    Stiasny, K
    Winkelmann, J
    Buhlinger, A
    Brandenburg, U
    Penzel, T
    Medori, R
    Rubin, M
    Oertel, WH
    Trenkwalder, C
    NEUROLOGY, 1999, 52 (05) : 944 - 950
  • [33] Restless legs syndrome: long-term follow-up of a series of patients
    Miranda C, Marcelo
    Hudson A, Lorena
    REVISTA MEDICA DE CHILE, 2016, 144 (12) : 1561 - 1566
  • [34] Pergolide:: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS).: Longterm follow up on pergolide -: Short communication
    Staedt, J
    Hünerjäger, H
    Rüther, E
    Stoppe, G
    JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (2-3) : 265 - 268
  • [35] Changes in neuroendocrine response to L-DOPA during long-term treatment in restless legs syndrome augmentation
    Garcia-Borreguero, D
    Egatz, R
    Larrosa, O
    Serrano, C
    MOVEMENT DISORDERS, 2004, 19 : S396 - S397
  • [36] Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial
    Montplaisir, Jacques
    Karrasch, Jeff
    Haan, Jean
    Volc, Dieter
    MOVEMENT DISORDERS, 2006, 21 (10) : 1627 - 1635
  • [37] Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation
    Mackie, Susan
    Winkelman, John W.
    CNS DRUGS, 2015, 29 (05) : 351 - 357
  • [38] Long-term course of restless legs syndrome in dialysis patients after kidney transplantation
    Winkelmann, J
    Stautner, A
    Samtleben, W
    Trenkwalder, C
    MOVEMENT DISORDERS, 2002, 17 (05) : 1072 - 1076
  • [39] Gabapentin Enacarbil in Subjects with Restless Legs Syndrome: Integrated Long-Term Safety Data
    Caivano, Christine
    VanMeter, Susan
    Kavanagh, Sarah
    Lassauzet, Marie-Liesse
    NEUROLOGY, 2011, 76 (09) : A340 - A340
  • [40] Long-term follow-up on restless legs syndrome patients treated with opioids
    Walters, AS
    Winkelmann, J
    Trenkwalder, C
    Fry, JM
    Kataria, V
    Wagner, M
    Sharma, R
    Hening, W
    Li, L
    MOVEMENT DISORDERS, 2001, 16 (06) : 1105 - 1109
12345